Fig. 1From: The efficacy of tofacitinib combined with bDMARDs in the treatment of ankylosing spondylitis patients with inadequate response to bDMARDs: a retrospective studyLine Chart of ASDAS changes at 0 and 12 weeks. ASDAS: Ankylosing Spondylitis Disease Activity ScoreBack to article page